Treatment of Parkinson's disease.
Parkinson's disease is a progressive neurodegenerative disorder that demands a holistic approach to treatment. Both pharmacologic and nonpharmacologic interventions play an important role in the comprehensive management of this disorder. While levodopa remains the single most effective medication for symptomatic treatment, dopamine agonists are playing an increasingly important role. Motor complications of dopaminergic therapy are a significant issue, particularly in patients with more advanced disease who have been on levodopa for several years. All therapeutic interventions must be tailored to the individual and modified as the disease progresses, with the goal of minimizing significant functional disability as much as possible.
Martin
W R Wayne
WR
Division of Neurology, University of Alberta, Edmonton, AB, Canada.
Wieler
Marguerite
M
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use; D020820:Dyskinesias / Q000209:etiology; D006694:Holistic Health; D006801:Humans; D007980:Levodopa / Q000009:adverse effects; D026201:Musculoskeletal Manipulations; D018696:Neuroprotective Agents / Q000627:therapeutic use; D009788:Occupational Therapy; D010300:Parkinson Disease / Q000451:nursing / Q000534:rehabilitation / Q000628:therapy*; D013070:Speech Therapy
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D018696:Neuroprotective Agents; D007980:Levodopa